The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries. We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems. 

CHAI was founded in 2002 in response to the HIV/AIDS epidemic, with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Over the following two decades, CHAI has expanded its focus. Today, along with HIV, we work in conjunction with our partners to prevent and treat infectious diseases such as COVID-19, malaria, tuberculosis, and hepatitis. Our work has also expanded into cancer, diabetes, hypertension, and other non-communicable diseases, and we work to accelerate the rollout of lifesaving vaccines, reduce maternal and child mortality, combat chronic malnutrition, and increase access to assistive technology. We are investing in horizontal approaches to strengthen health systems through programs in human resources for health, digital health, and health financing. With each new and innovative program, our strategy is grounded in maximizing sustainable impact at scale, ensuring that governments lead the solutions, that programs are designed to scale nationally, and learnings are shared globally.  

At CHAI, our people are our greatest asset, and none of this work would be possible without their talent, time, dedication and passion for our mission and values. We are a highly diverse team of enthusiastic individuals across 40 countries with a broad range of skill sets and life experiences. CHAI is deeply grounded in the countries we work in, with the majority of our staff based in program countries. 

Clinton Health Access Initiative India Private Limited (CIPL) is a private entity, majority-owned by the Clinton Health Access Initiative (CHAI), a US-based non-profit organization. CIPL operates independently and exclusively provides export-based services, contributing to CHAI’s goals of improving healthcare access, delivery, and outcomes in underserved populations. CIPL serves as a Global Shared Service (GSS) or Global Capability Center (GCC) harnessing technical expertise and innovative solutions to address global health challenges. 

CIPL is an Equal Opportunity Employer, and is committed to providing an environment of fairness, and mutual respect where all applicants have access to equal employment opportunities. CIPL values diversity, inclusion and recognizes that our mission is best advanced by the leadership and contributions of people with diverse experience, backgrounds, and culture.

Position Overview

The Associate Director will support the design and implementation of strategies for reducing morbidity and mortality of people living with HIV by strengthening the market and accelerating access to the Advanced HIV Disease (AHD) package of care. 

The role will require the employee to act as a thought leader and conduit between the CHAI teams focused on market shaping efforts, specifically act as bridge between HAP & GMT on market shaping deliverables for AHD therapeutics and diagnostics. The role holder will be responsible for co-developing strategy, execution, tracking progress, and mitigating risks. 

Additionally, the role holder will support the market shaping component for CHAI’s paediatric HIV strategy, support in new business development/fundraising efforts, and donor engagement as necessary.

• Drive market shaping interventions for the HAP team, across diagnostics, therapeutics for adults and paediatrics 
• Lead the market interventions to incentivize generic development of L-AmB in collaboration with DNDI and Unitaid
• Lead market shaping strategy for CD4, CrAg SQ, 5FC, L-AmB, Azithromycin, Fluconazole, and other commodities as necessary
• Conducting other tasks and work as mutually agreed with CHAI Senior Director, HIV Access Program

• Master’s degree in Public Health, Business Administration, Pharmacy, Life Sciences, Public Policy, or a related field with a minimum of ten years of relevant work experience in global health, healthcare market shaping, HIV program management, or access to medicines
• Proven experience in designing and executing market shaping strategies for therapeutics and diagnostics, preferably within HIV/AIDS programs or infectious diseases
• Strong understanding of HIV treatment and diagnostics landscape, particularly in relation to Advanced HIV Disease (AHD) and pediatric HIV care
• Demonstrated ability to engage with product development partnerships (such as DNDi), donors (such as Unitaid), generic pharmaceutical manufacturers, and other key stakeholders to drive access initiatives
• Experience in donor engagement, fundraising, and supporting new business development efforts in global health programs
• Excellent strategic thinking, project management, and risk mitigation skills, with the ability to manage complex, multi-country, multi-stakeholder initiatives
• Strong analytical and problem-solving skills, with the ability to track progress, adapt strategies based on emerging needs, and drive measurable outcomes
• Ability to work independently and collaboratively across multicultural teams and geographies, and to liaise effectively with internal teams such as HAP (HIV Access Program) and GMT (Global Markets Team)

#jobreference3 #region2